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Abstract
Background: Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of microRNAs in skin
development was shown in a keratinocyte-specific Dicer knockout mouse model. Considering that two main characteristics
of psoriasis are keratinocytes hyperproliferation and abnormal skin differentiation, we hypothesized that aberrant microRNA
expression contributes to the psoriatic phenotype. Here, we describe the differential expression of miRNAs in psoriatic
involved and uninvolved skin as compared to normal skin, revealing an additional aspect of this complex disorder.
Methodology/Principal Findings: Expression arrays were used to compare microRNA expression in normal skin versus
psoriatic involved and uninvolved skin. Fourteen differentially expressed microRNAs were identified, including hsa-miR-99a,
hsa-miR-150, hsa-miR-423 and hsa-miR-197. The expression of these microRNAs was reevaluated by qPCR. IGF-1R, which is
involved in skin development and the pathogenesis of psoriasis, is a predicted target of hsa-miR-99a. In an in situ
hybridization assay, we found that IGF-1R and miR-99a are reciprocally expressed in the epidermis. Using a reporter assay,
we found that IGF-1R is targeted by hsa-miR-99a. Moreover, over expression of miR-99a in primary keratinocytes down-
regulates the expression of the endogenous IGF-1R protein. Over expression of miR-99a also inhibits keratinocyte
proliferation and increases Keratin 10 expression. These findings suggest that overexpression of hsa-miR-99a in
keratinocytes drives them towards differentiation. In primary keratinocytes grown in high Ca
++, miR-99a expression
increases over time. Finally, we found that IGF1 increases the expression of miR-99a.
Conclusions/Significance: We identified several microRNAs that are expressed differentially in normal and psoriatic skin.
One of these miRNAs is miR-99a that regulates the expression of IGF-1R. Moreover, miR-99a seems to play a role in the
differentiation of keratinocytes. We suggest that miR-99a is one of the regulators of the IGF-1R signaling pathway in
keratinocytes. Activation of IGF1 signaling results in elevation of miR-99a which represses the expression of IGF-1R.
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Introduction
Psoriasis is a very common chronic inflammatory skin disorder
with an estimated prevalence of 2%. Despite the accessibility,
frequency and persistence of this complex disease that involves
different cell types and many genes, puzzling questions remain
unanswered [1]. Perhaps the most obvious is the lack of major
genetic susceptibility determinants, although several psoriatic
associated genes have been found (Reviewed in [2]). Susceptibility
to psoriasis has been mapped to loci on several chromosomes
[3,4,5,6,7,8,9]. This multigenic disease is characterized by abnor-
mally increased keratinocyte proliferation, abnormal differentiation
of the epidermis and systemic and local inflammation, which result
in the formation of chronic erythematous and scaly lesions
[1,10,11]. Psoriatic epidermal hyper proliferation is characterized
by over representation of basal keratinocytes, increased number of
mitoses and their presence above the basal layer, evenly thickened
epidermis with persistence of cell nuclei in the upper cornified layer,
and loss of the granular layer. Keratinocyte transit time through the
epidermis is accelerated 10-fold compared to normal skin, and
differentiated characteristics do not develop [12].
Since the discovery of the first microRNA (miRNA) gene,
lin-4, in Caenorhabditis elegans, approximately 700 miRNA genes
have been identified in humans [13]. MiRNAs play important
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esis, apoptosis and differentiation. The role of miRNAs in skin
development was demonstrated recently in a mouse model
constructed with conditional knockout of Dicer in the skin
[14,15]. Yi et al. found more than 100 miRNAs in the skin and
showed that epidermis and hair follicles differentially express
discrete miRNA families [15]. Loss of keratinocyte-specific Dicer
expression produces several distinct defects in the skin that affect
both the epithelium and epithelial-mesenchymal signaling. These
phenotypes include hyper proliferation in the absence of increased
apoptosis [14,15]. Hence, the importance of miRNAs in skin
development is evident, although their precise functions in normal
skin development and pathogenic conditions are unknown
(reviewed in [16]).
The psoriatic phenotype is characterized by keratinocytes hyper
proliferation and abnormal skin differentiation. Analysis of
keratinocyte-derived miRNAs arrays revealed that hsa-miR-203
is up-regulated in psoriatic plaques [17]. Yet, many of the
functions of miRNAs in the skin are largely unknown, and their
involvement in the pathogenesis of skin disorders is even less
understood. In this study we sought to identify miRNAs involved
in the pathogenesis of psoriasis. We compared miRNA expression
in normal skin to psoriatic involved and uninvolved skin and
revealed 14 novel differentially expressed miRNAs. We further
showed that IGF-1R, which has an important role in the psoriatic
phenotype, is regulated by hsa-miR-99a.
Results
MiRNA expression analysis
To identify miRNAs involved in psoriasis, we compared
miRNA expression in healthy skin to psoriatic involved an
uninvolved skin using microarray technology. Full skin biopsies
from three patients diagnosed with psoriasis were taken from
psoriatic lesions as well as from uninvolved skin near the lesion.
Normal skin biopsies were taken from three healthy volunteers.
MiRNAs were extracted from the three biopsy types and samples
from each type were pooled to reduce genetic variability.
The expression profiles of psoriatic uninvolved skin and
lesion skin were compared to that of normal skin (Figure 1A
and 1B, table S2 and table S1 respectively). As expected, the
expression level of most of the miRNAs was the same.
However, several miRNAs exhibited a significant difference
in expression in both comparisons. The following differentially
expressed miRNAs were specific to the normal versus psoriatic
uninvolved skin comparison: hsa-miR-199a*2, hsa-mir-186,
hsa-miR-22, hsa-miR-221 hsa-miR-220, hsa-miR-24-1, hsa-
miR-296, hsa-miR-331, hsa-miR-324-5p, hsa-miR-329 hsa-
miR-423 (hsa-miR-423 is marked as a red square in Fig. 1A).
(Figure 1A and Table S3). The comparison between normal
and psoriatic lesion skin revealed the following differentially
expressed miRNAs: hsa-miR-149, hsa-miR-150, hsa-miR-210,
hsa-miR-220, hsa-miR-326, has-miR-324-5p, hsa-miR-342,
hsa-miR-326, hsa-miR-328, hsa-miR-345, hsa-miR-346, hsa-
miR-197, (hsa-miR-197 is marked in brown in Fig 1B).
(Figure 1B and Table S2). Hsa-miR-99a and hsa-miR-150
were found to be differentially expressed, more than a 2-fold
difference, in both comparisons (Marked in blue and pink,
respectively in Fig 1A and 1B).
In addition, the expression of hsa-miR-423 (Figure 1A) and hsa-
miR-197 (Figure 1B) were dramatically changed, exhibiting more
than a 2-fold difference in expression. Thus, these four miRNAs
were chosen for further investigation. The array results are
depicted in Table S1, S2, S3, S4.
Validating the chip results
To verify the results obtained in the chip analysis, we assessed
the expression of hsa-miR-99a, hsa-miR-150, hsa-miR-197 and
hsa-miR-423 in normal and psoriatic uninvolved and lesion skin
using qPCR. RNA was extracted from biopsies taken from 10
healthy volunteers and 16 psoriasis patients. As before, two
biopsies were taken from each patient – one from the lesion and
one from uninvolved skin. The expression of hsa-miR-99a was
,4.5-fold lower in lesion skin and ,2-fold lower in uninvolved
skin as compared to normal skin (p,0.0001 P vs. N, using un-
paired t-test, Figure 2A). Hsa-miR-150 was under expressed in
uninvolved psoriatic skin, ,3-fold less than in normal and
psoriatic lesion skin (p,0.0007 in P vs. UI, using paired t-test,
P,0.0004 in UI vs. N, using un-paired t-test, Figure 2B). Hsa-
miR-423 was under expressed in uninvolved skin as well as in
psoriatic lesion skin, ,2.75 times less than in normal skin,
(P,0.0001 in P vs. N , P,0.0003 in UI vs. N, using un-paired t-
test, Figure 2C). Hsa-miR-197 was under expressed in psoriatic
lesion skin, ,3-fold less than in normal skin (P,0.0019 in P vs. N,
using un-paired t-test). Its expression in uninvolved skin was
similar to that in normal skin although the results were highly
variable (Figure 2D). Not all miRNAs were down regulated in the
psoriasis lesion; miR-203 was up regulated in psoriasis lesion
samples as compared to normal skin samples (Supporting
Information Figure S1) similar to previously published results
[17]. Interestingly, we also detected a significant down regulation
of miR-203 in the uninvolved psoriatic skin as compared to
psoriatic lesion and normal skin (p,0.009 and 0.0001, respec-
tively, Supporting Information Figure S1).
Next, we characterized the expression pattern of the four
miRNAs in the epidermis. In situ hybridizations (ISH) were
performed on biopsies of six psoriatic lesion skins, six uninvolved
skins and five normal skins using specific LNA probes for hsa-
miR-99a, hsa-miR-150, hsa-miR-423 and hsa-miR-197 (Figure 3).
The specificity of the probes was confirmed by hybridization with
an LNA scrambled-miRNA probe (data not shown). The ISH
showed that the four miRNAs are present in keratinocytes and
are differentially distributed throughout the epidermis. Hsa-miR-
99a was found to be expressed in the upper part of the epidermis
and excluded from the basal keratinocyte layer, in normal,
uninvolved and psoriatic lesion skin (Figure 3A). Hsa-miR-150
was found to be expressed in the upper part of the epidermis and
much less in the basal keratinocytes layer in normal skin. It was
completely excluded from uninvolved skin, and appeared to be
evenly distributed throughout the psoriatic epidermis (Figure 3B).
Hsa-miR-423 appeared to be evenly distributed throughout the
normal epidermis, and was hardly detected in the psoriatic lesion
and uninvolved skin (Figure 3C). In contrast to miR-99a and
miR-150, that were express gradually; higher in the upper
epidermis and decreasing until complete absent from the basal
layer, miR-197 was excluded from the basal layer of normal,
uninvolved and psoriatic lesion skin and also was absent in the
upper part of the epidermis in uninvolved and psoriatic lesion
skin. At the rest of the epidermis miR-197 seemed to express
equally (Figure 3D). The results of the ISH lack quantitative value
due to variability in the intensity of staining among the samples.
Nevertheless, the distribution of the four miRNAs was success-
fully demonstrated and the staining pattern was highly repro-
ducible.
Our microarray and qPCR analysis revealed that hsa-miR-150
expression differs significantly between normal, psoriatic lesion
and psoriatic uninvolved skin (Figures 1 and 2). Xiao et al.
showed that miR-150 is selectively expressed in mature resting B
and T cells, but not in their progenitors [18]. Our ISH analysis
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20916Figure 1. Profiling the expression level of miRNAs in psoriatic involved and uninvolved skin in comparison to normal skin. The
expression of individual miRNAs in biopsies of normal skin, and psoriatic uninvolved and lesional skin was determined using miRNA expression array
technology. The expression profile of normal skin was compared to uninvolved psoriatic skin (A) and psoriatic lesional skin (B). Abundance of an
individual miRNA is shown by its relative position along the scaled y and x axes (arbitrary units). The colored boxes denote miRNAs which were
further analyzed. See Table S1 for a detailed calculation of the heat-map.
doi:10.1371/journal.pone.0020916.g001
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In addition we found that hsa-miR-150 is expressed both in
HaCaT and PHK, reinforcing the fact that hsa-miR-150 is
expressed in keratinocytes. However, miR-150 expression in
keratinocytes is much lower than in B or T lymphocyte cell lines
(data not shown).
Reciprocal expression of IGF-1R and hsa-miR-99a
To understand the biological role of these differentially
expressed miRNAs and their involvement in psoriasis, we sought
to identify their possible targets. MiRNAs regulate gene expression
mainly through interaction with the 39UTR of a specific target
mRNA. The binding specificity is directed by what is known as the
miRNA ‘seed’ sequence: miRNA seeds are 7 to 8 nucleotides at
the 59 end that serve as the primary determinant of target
specificity [19]. Based on this, several algorithms were developed
to predict possible miRNA targets. We used these algorithms
(miRanda, TargetScan, TargetRank) to predict possible targets for
hsa-miR-99a. Between 40–950 predicted target mRNAs were
found, one of which was IGF-1R, which was predicted by several
algorithms. IGF-1R is known to be involved in the pathogenesis of
psoriasis [20,21]. IGF-1R was shown to be up-regulated in
psoriasis, specifically in the proliferating basal layer of psoriatic
lesions [20,22]. Our ISH analysis revealed that hsa-miR-99a is not
found in this layer (Figure 3A). We therefore decided to
characterize the distribution of hsa-miR-99a and IGF-1R in the
same sample to determine whether their expression pattern is
reciprocal. ISH with specific LNA probes to hsa-mir-99a assay was
performed on paraffin-embedded psoriatic lesion skin biopsies.
Hsa-miR-99a was expressed in the upper part of the epidermis,
most pronounced in the stratum spinosum and much less
pronounced in the stratum basal layer (Figure 4A) also in normal
skin (Figure 4C). The same biopsies were immunostained with
anti-IGF-1R antibodies. IGF-1R was indeed up-regulated in the
psoriatic lesions as compared to normal skin (Figure 4B and 4D) in
agreement with previously published findings [20,22]. Interesting-
ly, IGF-1R was detected mainly in the basal layer of the epidermis,
and was absent from the upper epidermal layer (Figure 4B). This
reciprocal expression pattern suggests a possible relationship
between hsa-miR-99a and IGF-1R.
In order to determine whether IGF-1R is a direct target of hsa-
miR-99a, we cloned a fragment of the IGF-1R 39UTR mRNA
downstream to the Renilla luciferase reporter gene [23]. Cells
were either transfected with IGF-1R 39UTR-luc alone, or
together with increasing amounts of a hsa-miR-99a expression
plasmid. The effect of miR-99a on the expression of the luciferase
reporter containing the IGF-1R 39UTR was assessed 72 h later
with a standard luciferase reporter assay. Figure 5A (middle
panel) shows that luciferase expression dropped to less than 50%
in the presence of miR-99a, as compared to the control in the
absence of miR-99a, or in the absence of the IGF-1R 39UTR.
These results suggest that hsa-miR-99a regulates the expression of
Figure 2. Quantification of miRNAs expression by qRT-PCR. The levels of hsa-miR-99a (A), hsa-miR-150 (B), hsa-miR-423 (C) and hsa-miR-197
(D) in normal skin (N, n=10), psoriatic lesional skin (P, n=16), and psoriatic uninvolved skin (UI, n=16) were quantified by qPCR, and normalized to
Rnu48. Each dot represents one sample. The average is denoted by the horizontal line. (A) Hsa-miR-99a (*p,0.0001 using un-paired t-test). (B) Hsa-
miR-150 (*p,0.0007 using paired t-test, **p,0.0004 using un-paired t-test). (C) Hsa- miR-423 (*p,0.0001, **p,0.0003 using un-paired t-test). (D)
Hsa-miR-197(**p,0.009 **p,0.0019 using un-paired t-test).
doi:10.1371/journal.pone.0020916.g002
MiRNA Expression in Psoriatic Skin
PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e20916Figure 3. in situ hybridization of hsa-mir-99, hsa-mir-150, hsa-mir-423 and hsa-mir-197 in normal, uninvolved and psoriatic skin.
Representative in-situ hybridization images showing distribution of hsa-miR-99a (A), hsa-miR-150 (B), hsa-miR-423 (C) and hsa-mir-197 (D) in psoriatic,
uninvolved and normal skin. In-situ hybridizations were performed on paraffin-embedded sections of the three skin biopsy types. Each section was
hybridized with an miRNA-specific LNA probe as indicated. Positive staining appears as a blue-purple color (examples are marked with blue arrows).
Samples were co-stained with Nuclear Fast Red counter stain to visualize nuclei that are stained pink (examples are marked with white arrows). All
images were captured at 200x magnification.
doi:10.1371/journal.pone.0020916.g003
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that the interaction between hsa-miR-99a and its predicted seed
response sequence in the IGF-1R 39UTR is responsible for down-
regulating the expression of the reporter gene. We generated an
IGF-1R-39UTR-luc mutant in which four nucleotides in the seed
response sequence were changed (TACGGGTA was changed to
TATAAATA). The mutant was co-transfected with the miR-99a
expression plasmid as before and luciferase activity was assessed.
Figure 5A (left panel) clearly demonstrates that miR-99a has no
effect on the mutated IGF-1R-39UTR, proving that miR-99a
seed sequence at the IGF-1R 39UTR is essential for the
regulation of IGF-1R by miR-99a. The effect of hsa-miR-99a
on the regulation of IGF-1R was further examined by assessing
IGF-1R mRNA and protein levels in primary human keratino-
cytes (PHK) transfected with RNA pre-miR-99a molecule. A
scrambled sequence was used as the control. qPCR analysis
showed that the level of IGF-1R mRNA in cells transfected with
pre-miR-99a is similar to that in all the controls (untransfected,
mock-transfected and scrambled-sequence-transfected cells;
Figure 5B and C). In contrast, the level of IGF-1R protein was
dramatically reduced in pre-miR-99a expressing cells, as
determined by Western blot analysis (Figure 5D). Thus, IGF-
1R is regulated at the post transcriptional level. Collectively, these
results support our hypothesis that IGF-1R is a direct target of
hsa-miR-99a.
Hsa-miR-99a affects proliferation and differentiation of
keratinocytes
Thus far, we demonstrated the reciprocal expression pattern of
hsa-miR-99a and IGF-1R in the epidermis (Figure 4), and
provided evidence for the direct regulation of IGF-1R by hsa-
miR-99a (Figure 5). The role of IGF-1R in proliferation of the skin
is well established [24]. Our results suggest that miR-99a might be
a key regulator of skin homeostasis. We first determined the effect
of hsa-miR-99a on keratinocytes proliferation in the human
keratinocyte cell line, HaCaT. Stable cell lines were established in
HaCaT cells by transfections with an hsa-miR-99a expression
plasmid (pMSCV-hsa-miR-99a) or a control plasmid expressing
an unrelated small RNA molecule, HTR (pMSCV-HTR) followed
by growth in selective medium [23]. The MTT assay was applied
and viable cell count was evaluated over time. At 24 h after
seeding, the growth rate of cells expressing hsa-mir-99a and HTR
was similar. However, with time, the growth rate of the hsa-miR-
99a expressing cells slowed down as compared to control cells. By
72 h, the hsa-miR-99a expressing cells had stopped proliferating,
whereas the control cells continued to proliferate (Figure 6A). To
confirm the effect of hsa-miR-99a on keratinocytes proliferation,
we performed a BrdU incorporation assay in the two stable cell
lines. The same trend demonstrated by the MTT assay was
observed, but with different kinetics (Figure 6B). Thus, both
Figure 4. Reciprocal expression of IGF-1R and hsa-miR-99a. The distribution of hsa-miR-99a in psoriatic lesional skin (A) or normal skin (C) was
assessed by in-situ hybridization. Paraffin-embedded sections of lesional skin biopsies were hybridized with an LNA probe specific to hsa-miR-99a.
The cytoplasm of positive cells was stained blue (indicated by black arrows). Nuclei were stained with Nuclear Fast Red counter stain (indicated by red
arrows). Magnification, 200x. (B) and (D) The same paraffin-embedded skin biopsy shown in (A and Crespectively;) was immunostained with anti-IGF-
1R antibodies. Antibody binding was visualized with the substrate-chromogen AEC. IGF-1R positive cells were stained red (indicted by the red arrow).
Nuclei were stained blue with hematoxylin (indicated by the black arrow). Magnification, 200x.
doi:10.1371/journal.pone.0020916.g004
MiRNA Expression in Psoriatic Skin
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20916Figure 5. 39 UTR of IGF-1R is a target of hsa-miR-99a seed sequence. (A) 293T cells were transfected with psi-CHECK2 vectors encoding
luciferase (right panel), luciferase fused to the IGF-1R 39UTR (middle panel), or luciferase fused to a mutated IGF-1R 39UTR (left panel) together with
increasing amounts of an hsa-miR-99a expression plasmid as indicated. A scheme of the reporter vectors is shown under each panel. Luciferase
activity was assessed 72 h later, and is depicted relative to that of the control cells transfected with psi-CHECK2 alone (given a value of 100%). Results
represent the mean of triplicates. # p,0.0071, ##p,0.0047, * p,0.0075, ** p,0.0007. (B–C) PHK cells were transfected with 10 nM pre-miR-99a, a
scrambled sequence, mock transfected or left untransfected. RNA was extracted 120 h later, and the level of hsa-miR-99a (B) and IGF-1R mRNA (C)
MiRNA Expression in Psoriatic Skin
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99a on keratinocyte proliferation.
Next, we determined the effect of hsa-miR-99a on keratinocyte
differentiation. The expression of two keratinocyte differentiation
related genes, Keratin14 (K14) and Keratin10 (K10), was
evaluated in the two stable cell lines. K14 expression in normal
skin is restricted to the basal layer, while K10 is expressed in more
differentiated cells [25]. Total RNA was extracted from the two
cell lines and RT-PCR was used to amplify K14 and K10 mRNA.
Figure 7A shows that K10 expression is elevated and K14 is
slightly decreased in the hsa-miR-99a expressing cells as compared
to control cells. The same changes in expression were observed by
qPCR analysis (Figure 7B and C). Furthermore, primary
keratinocytes grown in high Ca
++ medium, conditions known to
induce keratinocyte differentiation [26], exhibited an increase in
hsa-miR-99a expression over time, as determined by qPCR
(Figure 7D).
We next determined the effect of hsa-miR-99a depletion on
keratinocyte proliferation. A knockdown of miR-99a using antago-
mir did not significantly change the growth rate or proliferation in
PHK cells (data not shown). In addition, we used a sponge system
to knockdown hsa-miR-99a in PHK cells [27,28]. In order to
verify that the miR-99a sponge is active, we co-transfected 293
cells with luciferase-IGF-1R-39UTR and hsa-miR-99a expression
plasmids together with variable amounts of the sponge expressing
plasmid. As expected, luciferase expression was reduced to about
50% in cells transfected with the 39UTR of IGF-1R and hsa-miR-
99a as compared to control cells expressing hsa-miR-99a and the
empty luciferase reporter plasmid. However, in the presence of the
miR-99a sponge, the miR-99a-induced repression was released;
the luciferase level in cells transfected with 4 mg of sponge plasmid
was almost completely restored to that of the control (Supporting
Information Figure S2). We generated cell lines of HaCaT cells
stably expressing the miR-99a sponge or the empty vector control
and assessed their proliferation rate using the MTT assay. No
significant difference in proliferation rate was observed between
the miR-99a sponge expressing and control cell lines (Supporting
Information Figure S2). However, a minor but not significant
enhancement of IGF-1R protein level was detected in the miR-
99a sponge expressing cell line as compared to the control cell line
(Supporting Information Figure S2), in agreement with our results
demonstrating that IGF-1R is a target of miR-99a (Figure 5). We
also determined whether the miR-99a sponge has an effect on
keratinocyte differentiation. As shown in Supporting Information
Figure S2, there is no change in expression of keratin-10 or
keratin-14.
These results indicate that the over-expression of hsa-miR-99a
slows keratinocyte growth rate and directs them towards differ-
entiation. As shown in Figure 5, miR-99a regulates the expression
of IGF-1R. IGF-1R was shown to have a major role in
keratinocyte differentiation [24]. Considering these two facts, we
thought that the expression of miR-99a and IGF-1R might be
correlated. To further investigate the relationship between miR-
99a and IGF-1R, we assessed miR-99a expression in serum-
starved PHK cells treated with increasing concentrations of IGF1.
Total RNA was extracted 72 h after IGF1 addition, and the miR-
99a level was determined by qPCR. The expression of miR-99a
was significantly increased in cells treated with 1–25 nM of IGF1
as compared to untreated cells (Figure 8A). Collectively, our results
suggest that miR-99a and IGF-1R are co-regulated, functioning
together to maintain the balance between keratinocyte prolifera-
tion and differentiation.
Discussion
MiRNAs are major regulatory molecules that govern many
essential cellular functions, including proliferation, differentiation,
cell cycle control and apoptosis. The significance of miRNAs in
skin development was demonstrated by Yi et al., who showed that
skin formation is impaired in keratinocyte-specific Dicer knockout
mice [14,15]. A recent comparison of miRNA expression profiles
of psoriatic and normal or atopic dermatitis skins revealed several
leukocyte-derived miRNAs and one keratinocyte-derived miRNA,
miR-203, which were up-regulated in psoriatic skin [17]. The
functions of miR-203 seem to be related to keratinocyte stem cell
differentiation [29]. Furthermore, the transcription factor p63,
which plays an essential role in epidermis formation, is a target of
miR-203 [29]. Our qPCR analysis of miR-203 expression
demonstrated that it was up regulated in psoriatic skin compared
was quantified by qPCR. Results represent the means of triplicates. Error bars, SD. (D) PHK cells were either mock-transfected or transfected with
10 nM pre-miR-99a, or a scrambled sequence. Cells were processed for Western blotting 120 h later to detect the level of IGF-1R protein. b-actin was
used as the loading control. (E). The level of IGF-1R was quantified from the Western blot described in (D) by densitometry (EZQuant-Gel). Results
represent the means of triplicate Western blots. Error bars, SD.
doi:10.1371/journal.pone.0020916.g005
Figure 6. Hsa-miR-99a effect on keratinocytes cell growth.
Proliferation of HaCaT cells stably expressing hsa-miR-99a or the HTR
control RNA was assessed by MTT (A) and BrdU incorporation (B) assays.
Proliferation was calculated as the percentage of the reading at seeding
time (t=0) given a value of 100%. Mean and standard deviation were
calculated from 3 independent experiments. *P=0.0037 in (A) and
*P,0.0211**P,0.0420 in (B).
doi:10.1371/journal.pone.0020916.g006
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[17]. Unpredictably, hsa-miR-203 was significantly down regulat-
ed in uninvolved psoriatic skin compared to normal as well as
psoriatic skin (Supporting Information Figure S1). This result
implies that down regulation of miR-203 in uninvolved psoriatic
skin may predispose psoriatic uninvolved keratinocytes to hyper
proliferation and should be investigated in further studies.
Our comparison of miRNA expression profiles in normal,
psoriatic lesion and uninvolved skin revealed several novel
candidate miRNAs that might be involved in the pathogenesis of
psoriasis (Figure 1). We focused our investigation on hsa-miR-99a,
hsa-miR-150, hsa-miR-197 and hsa-miR-423, as they exhibited a
significant difference in expression (more than 2-fold) (Figure 1
and Supporting Information Table S1). We verified the expression
of these four miRNAs as well as miR-203 in skin biopsy types
using qPCR, confirming their differential expression in normal
and psoriatic skin (Figure 2 and Supporting Information Figure
S1). Interestingly, miR-203 and miR-150 were down-regulated in
uninvolved skin as compared to normal skin or lesional skin
(Figure 2B and Supporting Information Figure S1), suggesting that
in uninvolved skin of psoriasis patients down regulation of these
two miRNAs predisposes them to the psoriatic phenotype. The
Figure 7. Hsa-miR-99a effect on differentiation of keratinocytes. (A–C) The levels of K10 and K14 differentiation markers were assessed in
HaCaT cells stably expressing hsa-miR-99a or the HTR control RNA by RT-PCR (A) and qPCR (B–C) analysis. (D) PHK cells were seeded in high, 1.5 mM
Ca
++ medium. Cells were harvested at the indicated time points and the level of endogenous miR-99a was determined by qPCR.
doi:10.1371/journal.pone.0020916.g007
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psoriasis lesion were down-regulated compared to normal skin.
However, their average expression in the uninvolved skin of
psoriasis patients differed; average expression of miR-99a was
somewhere between normal and lesion expression levels
(Figure 2A), expression of miR-423 was down regulated in
uninvolved skin as in the lesion skin in comparison to normal
skin (Figure 2C) and miR-197 expression in uninvolved skin was
similar to that in normal skin (Figure 2D). This might suggest a
biochemical hierarchy in the development of the psoriatic lesion.
We characterized the distribution of the four miRNAs in the
epidermis by performing ISH on skin biopsies. This analysis
revealed that the four miRNAs are expressed in keratinocytes. In
addition, all four miRNAs were either absent or weakly expressed
in the basal keratinocyte layer, whereas only hsa-miR-99a, hsa-
miR-150 and hsa-miR-423 were present in the upper part of the
epidermis (Figure 3). This distribution suggests that these miRNAs
have the potential to regulate keratinocyte proliferation and
differentiation.
Hsa-miR-150 was shown to be involved in immune cell
function. It is selectively expressed in mature resting B and T
cells, controlling B-cell differentiation by targeting the transcrip-
tion factor c-Myb [18]. The involvement of the immune system in
psoriasis is well established [10,30,31,32], so it is possible that
hsa-miR-150 targets immune system regulators in the skin. A
possible target of hsa-mir-150 is IL-7 that is expressed in
keratinocytes [33] and is up-regulated in psoriatic lesions [34].
Another possible target is IRAK2 encoding the interleukin-1
receptor-associated kinase 2 that was reported to participate in the
IL1-induced up-regulation of NF-kappaB, a pathway known to be
involved in the pathogenesis of psoriasis [35]. In addition to a
possible role in immune system regulation, hsa-miR-150 might
regulate keratinocyte proliferation. Indeed, Wu et al. found that
miR-150 promotes gastric cancer proliferation by negatively
regulating the pro-apoptotic gene EGR2 [36]. Further investiga-
tion is required to identify the targets of hsa-miR-150 in
keratinocytes.
We focused on identifying the targets of hsa-miR-99a, the
miRNA exhibiting the strongest down-regulation in psoriatic skin
(Figure 2A). We used bioinformatics tools to predict possible
targets of hsa-miR-99a, and decided to focus on one predicted
target, IGF-1R, that is known to be involved in the pathogenesis of
psoriasis [20,21]. ISH revealed that both hsa-mir-99a and IGF-1R
are expressed in the psoriatic lesion. However, the distribution of
their expression is reciprocal, with a high expression of IGF-1R in
the basal epidermis layers, from which hsa-miR-99a is absent, and
a high expression of hsa-miR-99a in the upper epidermis, from
which IGF-1R is absent (Figure 4). Furthermore, we used a
standard luciferase reporter assay to demonstrate that the 39UTR
of IGF-1R is regulated by hsa-miR-99a and that this regulation is
dependent on the interaction between the hsa-miR-99a seed and
the IGF-1R mRNA 39UTR (Figure 5A). Moreover, we showed
that over expression of hsa-miR-99a reduces endogenous IGF-1R
protein levels without affecting its transcript levels, demonstrating
post-transcriptional regulation of IGF-1R (Figure 5C and D).
Thus, we provide strong evidence for the direct regulation of IGF-
1R by hsa-miR-99a.
MiRNAs are highly expressed in embryonic tissues [37] and are
known to have a key role in differentiation and development. Two
main characteristics of psoriasis are keratinocyte hyper prolifera-
tion and abnormal differentiation. IGF-1R plays an important role
in keratinocyte differentiation by actively inhibiting the differen-
tiation process [24]. Ablation of IGF-1R expression eliminates this
inhibition, resulting in facilitated differentiation [24]. Our results
suggest that hsa-miR-99a contributes to the homeostasis of IGF-
1R expression. We hypothesize that the elevation of IGF-1R in the
psoriatic lesion drives the tissue towards proliferation. One of the
possible physiological responses to such a situation is up-regulation
of hsa-miR-99a expression which may slow keratinocyte prolifer-
ation and induce their differentiation. Indeed, HaCaT cells
transfected with hsa-miR-99a expression plasmid exhibited a
decreased proliferation rate and an increase in expression of a late
differentiation marker as compared to control cells (Figures 6 and
7A–C). Moreover, miR-99a expression was up regulated in
differentiating PHK cells grown in high calcium medium
(Figure 7D). We also examined the effect of down regulating
hsa-miR-99a in HaCaT cells. Using a sponge system, we
demonstrated that IGF-1R expression is up-regulated in hsa-
miR-99a-depeleted cells (Supporting Information Figure S2),
however the proliferation rate was unchanged (Supporting
Information Figure S2). It is possible that the combined effect of
several regulators is required to achieve the hyper proliferation
phenotype. Lastly, the relationship between hsa-miR-99a and
IGF-1R was further demonstrated by an increase in endogenous
hsa-miR-99a expression in PHK cells treated with IGF-1
(Figure 8A). We propose a model to describe how hsa-miR-99a
and IGF-1R work together to achieve a balance between
proliferation and differentiation in the skin (Figure 8B). Activation
Figure 8. hsa-miR-99a expression in primary human keratino-
cytes 72 h after IGF1 addition. (A) Serum-starved PHK cells were
treated with increasing concentrations of IGF-1 as indicated. The cells
were harvested 72 h later and the level of endogenous miR-99a was
determined by qPCR (*p=0.0027 **p=0.04510). (B) Proposed model
describing the relationship between IGF-1R and miR-99a. IGF1
activation of IGF-1R inhibits differentiation and promotes proliferation
of keratinocytes [24]. IGF-1R signaling enhances the expression of miR-
99a that in turn inhibits IGF-1R expression. This negative feedback loop
maintains the balance between proliferation and differentiation in the
skin.
doi:10.1371/journal.pone.0020916.g008
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ation. Over time, IGF-1R signaling up-regulates the expression of
miR-99a that in turn down-regulates the expression of IGF-1R,
driving the cells toward differentiation. Is the entire effect of miR-
99a on keratinocyte differentiation mediated through its effect on
IGF-1R? It is possible; however, it is not probable, since miRNAs
usually have more than one target. Our model fits well with the
work of Yi et al in which miR-203 was given a comparable role in
restricting proliferation and inducing differentiation of keratino-
cytes [38]. Based on our results and previous studies, we suggest
that keratinocytes in the psoriatic lesion are prompted to
proliferation, possibly by mediators produced by immune
system cells. These mediators may either directly or through the
involvement of stromal cells, enhance over proliferation of
keratinocytes in the basal layer. During the passage of these cells
from the basal layer into the stratum spinosum, differentiation
signals are activated; our study describes one such signal, involving
hsa-miR-99a-mediated suppression of IGF-1R expression.
In addition we found that some of the miRNAs we analyzed are
expressed differentially in the uninvolved skin compared to normal
skin. These results prove that the uninvolved skin of psoriasis
patients differs from normal skin. This fact suggests that the
regulation of miRNA expression plays a major role in the
pathogenesis of psoriasis. Are the psoriatic uninvolved keratino-
cytes more susceptible to inflammatory mediators? It is interesting
to further investigate if these differences can be used as diagnostic
markers or as therapeutic agents.
This study raises additional questions: Is the activation of these
miRNAs specific to the psoriasis lesion? The process by which
proliferating keratinocytes eventually differentiate is common to
several additional inflammatory skin disorders and wound healing.
Are the same miRNAs involved in all these biological processes, or
do specific miRNAs act in specific processes? The answers to these
questions will shed light on our understanding of the differences
between these disorders.
Materials and Methods
Patients
All skin donors were of Caucasian origin aged 18 to 85 years
(Table S5). All patients were clinically diagnosed with Psoriasis
Vulgaris, and did not receive systemic immunosuppressive
treatment, phototherapy (Psoralen and UVA (PUVA)/solarium/
UVB), or topical therapy for at least 3 weeks prior to skin biopsy
(for further details see, Table S5). Three mm punches were taken
mostly from upper and lower limbs. The uninvolved samples were
taken from the same area, about 5 cm away from the lesion
biopsy. Normal skin biopsies were taken from full thickness skin
remaining after plastic surgery. All the biopsies were evaluated by
a dermatopathologist for histological diagnosis. Half of each biopsy
was snap-frozen and the other half was embedded in paraffin. The
study was approved by both the Tel Aviv University and Sheba
Medical Center Helsinki Ethics Committees. All participants
provided written informed consent.
MiRNA array
Total RNAincludingmiRNAs from normal skin (n=3),psoriatic
lesion (n=3), or psoriatic patient uninvolved skin (n=3), was
isolated using Ambion mirVana
TM miRNA Isolation Kit. Total
RNA (2 mg) from each sample was labeled with the mirVana
miRNA Labeling Kit (Applied Biosystems/AmbionUSA). The
fluorescently-labeled RNA samples were hybridized to an expres-
sion array as previously described [39]. The array was scanned and
analyzed usingGenepix pro 4000b Axon and JMPstatisticsoftware.
Cells cultures
293T and HaCaT cells were grown in DMEM and MEM
medium, respectively, supplemented with glutamine, antibiotics
and 10% fetal bovine serum (Biological Industries, Israel) in a 5–
8% CO2 incubator at 37uC.
PHK cells were grown in an 8% CO2 incubator at 37uC, in high
Ca
++ (1.5 mM) medium: DMEM / HAM (Biological Industries,
Israel) /10%FBS (Gibco). Keratinocytes were harvested from
mashed skin (left over from plastic surgery) and grown on a feeder
layer of 5000 rad c irradiated 3T3 mice fibroblast cells.[40].
Cell growth and proliferation assays
Cell growth was assessed by seeding 3000 HaCaT cells per well
in 96-well plates. Viable cell counts were monitored from seeding
time (t=0) to 72 h. Cell counts were determined using the MTT
(3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide)-
based Cell Growth Determination Kit TOX-1 (Sigma-Aldrich,
Israel Ltd. Rehovot 76100 ISRAEL) and the BrdU colorimetric kit
(cat. 11 647 229001Roche), according to the manufacturer’s
instructions Each experiment was performed in triplicate.
Quantitative real time PCR (qPCR)
Total RNA of skin biopsies and cells was extracted using Ambion
mirVana
TM miRNA Isolation Kit. Quantification of miRNAs by
TaqManH Real-Time PCR was performed on 10 ng RNA using the
ABI 7900HT thermocycler (Applied Biosystems) for 40 cycles.
Target miR/ gene expression was normalized between differ-
ent samples based on the values of RNU48/Rplpo expression
respectively.
In situ hybridization
In situ transcriptional levels of the different miRNAs were
evaluated on paraffin-embedded skin biopsy specimens from 3
healthy skins and 5 psoriasis patients volunteers. Formalin-fixed
tissues were dehydrated, embedded in paraffin and sectioned at
4 mm. A section of a healthy volunteer skin biopsy and 2 sections
of involved and uninvolved skin from a psoriatic patient were
placed on each slide. The slides were warmed up to 60uC for 1 h,
de-waxed in xylene and rehydrated. Sections were hybridized
overnight with digoxygenin-labeled miRCURY LNA probes
(Exiqon, Denmark), and incubated with anti-digoxygenin antibody
conjugated with alkaline phosphatase for 1 h. The color reaction
was performed at 1–48 h. Counter staining was done by Nuclear
Fast Red counter stain. The stained sections were reviewed with a
light microscope and analyzed by a dermato pathologist who was
blind to the tissue origin.
IGF-1R immunostaining
The formalin-fixed tissues were treated in the same manner as
the ISH slides. Antigen retrieval was performed using a pressure
cooker (Milestone, Microwave Laboratory Systems) at 120uC for
5 min in 0.1 M citrate buffer pH 6. The slides were blocked in 3%
H2O2/MeOH and then incubated with primary antibody to IGF-
1R (Abcam, ab54274, 1:750). Detection was performed with the
Histostain SP Broad Spectrum kit (Zymed Laboratories, Inc.
USA). The antibody binding was visualized with the substrate-
chromogen AEC, counterstained with hematoxylin.
Cloning and plasmids
The plasmids pMSCV-miR-99a and pMSCV-HTR were
kindly provided by Agami, R.[23].
A genomic fragment containing 1070 bp of the 39UTR of IGF-
1R mRNA (NCBI Reference Sequence: NM_000875.3) from
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primers:
1-59-ACAGGTCAGAGGGTTTC-39;2 -5 9-CAGTCAAGT-
CTTCCCATGT-39.
PCR fragments were cloned into pCRII-TOPO plasmid
(Invitrogen,USA). The XhoI fill-in KpnI fragment was cloned
into psiCHECK-2 plasmid (Promega,USA) digested with XhoI
and PmeI.
An IGF-1R 39UTR mutant for the hsa-mir-99a seed sequence
was created using the Megaprimer Mutagenesis assay [41,42]
using primer 1 and primer 3: 59-TAGATTATAAATAGT-
CAGTT-39.
The hsa-miR-99a over expression oligo, Pre-miR miRNA
precursor, was purchased from Ambion- Applied Biosystems. The
miR-99a sponge expression plasmid was generated as follows: two
complementary oligo nucleotides of ,120 bases were synthesized
and annealed generating double stranded DNA containing four
hsa-mir-99a ‘‘sponge’’ sequences with XhoI and XmaI restriction
sites on either end. The double stranded DNA was cloned into
XhoI and XmaI sites of pTurbofp635-c plasmid (Evroege, Russia).
DNA synthesis and the cloning was performed by GenScript USA.
Determination of mRNA levels by RT-PCR
Total RNA was extracted using mirVana
TM isolation kit (Applied
Biosystems/Ambion, USA). RT-PCR was performed using the
Verso thermo-scientific kit using the following primers:
krt14: 59-AGCAGCAGAACCAGGAGTAACAAG-39
59-GGCGTAGGTGGCGATCT-39
krt10: 59- GCTGACATCAACGGCCT-39
59- AGCATTCATTTCCACATTCAC-39
b-actin: 59- CCTGGCACCCAGCACAAT -39
59- GCCGATCCACACGGAGTACT -39
Transfections
293T cells were seeded at 0.5–1610
5 cells per well and
transfected by calcium phosphate in HEPES buffer method, as
described [43].
HaCaT cells were transfected using Lipofectamine
TM 2000
Reagent (Invitrogen,USA).
Luciferase Assay
Luciferase assay was performed 72 h post transfection using the
The Dual-LuciferaseH Reporter (DLR) Assay System (Prome-
ga,USA).
Determination of protein expression level by Western
blotting (WB)
WB was performed as described previously [44], using primary
specific antibody (IGF-1Rb c20 CS-713 Santa Cruz Biotechnol-
ogy, USA)/ (Beta Actin AC-15 (Abcam UK).
Supporting Information
Figure S1 The level of hsa-miR-203 in normal skin (N, n=10),
psoriatic lesional skin (P, n=16), or psoriatic uninvolved skin (UI,
n=16) was determined by qPCR and normalized to Rnu48. Y
bars are arbitrary units that define fold change. Each dot
represents one sample. Average is denoted by the horizontal line.
*P,0.009,**p,0.0001.
(DOC)
Figure S2 A) 293T cells were co-transfected with 10 ng
psiCheck vector, or psiCheck-IGF-1R-39UTR plasmid, together
with 2 mg of hsa-miR-99a expressing plasmid. In addition cells
were transfected with 0 mg, 2 mg, or 4 mg of miR-99a sponge
expressing plasmid. 48 hours post transfection cells were harvested
and subject to Dual-Luciferase Reporter assay. Each experiment
was done in triplicates. The average of 3 wells transfected with
vector lacking the IGF-1R 39UTR and without miR-99a sponge
expressing plasmid (vector+0) was valued as 100%. The average is
of 4 independent experiments. Paired t test results; # p,0.0044,
*p ,0.0052. B) HaCaT cells were stably transfected with plasmid
expressing miR-99a sponge, or with the vector plasmid. After,
almost two months of G418 selection, the same amount of cells
from each plate were harvested and subjected to Western blot
analysis, using either IGF1R or actin antibodies, the graph is
average of three experiments; densitometry and calculation were
done with ImageJ. C) MTT assay of HaCaT cells expressing the
miR-99a sponge plasmid (sponge) or the empty vector (vector).
4000 cells were seeded in each well of 96 well plates. 4 h after
seeding MTT was added and counted as time 0. The graph
represents an average of three experiments, in each experiment
every time point is an average of three wells. D) Total RNA was
extracted form vector expressing or miR-99a sponge expressing
cells, and was subject to RT-PCR using specific primers as
indicated, the graph is average of three experiments; densitometry
and calculation were done with ImageJ.
(DOC)
Table S1 Summary of miRNAs that were change in each of the
comparisons also marked whether these miRNAs were up
regulated, or down regulated, or unchanged. In each miRNA
the fold change is noted, marked in yellow these miRNAs that
were chosen for further analysis. In the comparison of normal to
psoriatic skin also added miRNAs that were shown to change by
Sonkoly et. al.[2]. Among these miR-133a was marked as miRNA
that did change in there work by 1.76 fold, and in our screening
miR-133a did change by 1.8 fold (marked in blue), however, we
defined as change two fold or more.
(DOC)
Table S2 Comparison of normal versus psoriatic le-
sional skin. Total RNA from normal skin (n=3), psoriatic lesional
(n=3), was isolated using Ambion mirVana
TM miRNA Isolation Kit.
Two mgo ft o t a lR N Af r o me a c hs a m p l ew e r el a b e l e dw i t ht h e
mirVana miRNA Labeling Kit (Applied Biosystems/Ambion Austin,
TX 78744-1832, USA). The normal was labeled red and the psoriasis
green. The fluorescently-labeled RNA samples were hybridized to an
expression array as previously described [1]. The array was scanned
and analyzed using Genepix pro 4000 b Axon and JMP statistic
software. After background-subtracted, normalized spot intensities
presented as loge of the scanned value, ratio calculated of N to P for
individual spot is note (Each miRNA is represented on the CHIP
either 4 or 8 times; the value is an average of all spots of the same
miRNA).MiRNAsthat were found to change morethantwo fold are
highlighted as well as miRNAs that were further analysis.
(DOC)
Table S3 Comparison of normal versus uninvolved
psoriatic skin. Total RNA from normal skin (n=3), or psoriatic
uninvolved skin (n=3) was isolated using Ambion mirVana
TM
miRNA Isolation Kit. Two mg of total RNA from each sample
were labeled with the mirVana miRNA Labeling Kit (Applied
Biosystems/Ambion Austin, TX 78744-1832, USA). The normal
was labeled green and uninvolved red. The fluorescently-labeled
RNA samples were hybridized to an expression array as previously
described [1]. The array was scanned and analyzed using Genepix
pro 4000 b Axon and JMP statistic software. After background-
subtracted, normalized spot intensities presented as loge of the
scanned value, ratio calculated of N to UI or for individual spot is
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PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e20916note (Each miRNA is represented on the CHIP either 4 or 8 times;
the value is an average of all spots of the same miRNA). MiRNAs
that were found to change more than two fold are highlighted as
well as miRNAs that were further analysis.
(DOC)
Table S4 Comparison of psoriatic versus uninvolved
psoriatic skin. Calculation were taken from tables S2 and table
S3 After background-subtracted, normalized spot intensities
presented as loge of the scanned value, ratio calculated of UI to
P for individual spot is note (Each miRNA is represented on the
CHIP either 4 or 8 times; the value is an average of all spots of
the same miRNA). MiRNAs that were found to change more
than two fold are highlighted as well as miRNAs that were further
analysis.
(DOC)
Table S5 Patient characteristics.
(DOC)
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